|2005N-0345|| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product|
|FDA Comment Number :||EC722|
|Submitter :||Mr. Wendell Neugebauer||Date & Time:||10/12/2005 06:10:47|
|Organization :||Mr. Wendell Neugebauer|
|Category :||International Public Citizen|
| The World Health Organization has declared that oral contraceptives are a Group 1 carcinogen (Press Release #167, July 29, 2005).
The FDA should not approve of the morning after pill (a.k.a. Plan B, emergency contraception) or contraceptives in general, either by prescription or OTC.
Why should the FDA recommend a carcinogen?